Gilead Sciences, Inc. (GILD) NASDAQ
134.94
+1.42(+1.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
134.94
+1.42(+1.06%)
Currency In USD
| Market Cap | 152.69B |
| Enterprise Value | 169.72B |
| P/E Ratio | 18.19 |
| PEG Ratio | 0.33 |
| Price/Sales Ratio | 5.63 |
| Price/Book Ratio | 7.13 |
| Enterprise/Revenue | 6.12 |
| Enterprise/EBITDA | 13.66 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.31 |
| Operating Margin | 0.38 |
| Return On Assets | 0.16 |
| Return On Equity | 0.42 |
| Revenue | 29.44B |
| Revenue/Share | 23.94 |
| Gross Profit | 23.21B |
| EBITDA | 13.58B |
| Net Income | 8.51B |
| Diluted EPS | 6.78 |
| Total Cash | 9.82B |
| Total Cash/Share | 7.9 |
| Total Debt | 22.17B |
| Total Debt/Equity | 0.94 |
| Current Ratio | 1.97 |
| Book Value Per Share | 18.87 |
| 52-Week Change | 33.04 |
| 52-Week High | 157.29 |
| 52-Week Low | 97.86 |
| Moving Average 50 Days | 138.28 |
| Moving Average 200 Days | 127.59 |
| Average Volume | 6.2M |
| Shares Outstanding | 1.24B |
| % Held by Institutions | 87.7 |
| Trailing Annual Dividend Rate | 3.19 |
| Trailing Annual Dividend Yield | 2.36 |
| Payout Ratio | 0.44 |
| Last Split Factor | 2:1 |
| Last Split Date | January 28, 2013 |